These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 392813)

  • 1. A biological study on hot-water extract from delipidated Mycobacterium bovis strain BCG.
    Sato H; Motomiya M; Yokosawa A; Arai H; Nagai H; Kumano N; Konno K
    Tohoku J Exp Med; 1979 Nov; 129(3):285-93. PubMed ID: 392813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of hot-water extract from delipidated BCG.
    Sato H; Yokosawa A; Arai H; Nagai H; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1978 Jul; 125(3):247-52. PubMed ID: 358496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and biological properties of hot water extract from delipidated cells of Mycobacterium bovis strain BCG.
    Sato H; Yokosawa A; Arai H; Nagai H; Kurita K
    Tohoku J Exp Med; 1976 Sep; 120(1):75-81. PubMed ID: 785698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemistry and biology of a hot water extract from delipidated Mycobacterium bovis, strain BCG.
    Yokosawa A
    Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):65-82. PubMed ID: 379996
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study on a hot-water extract from delipidated BCG (author's transl)].
    Sato H; Sato K; Ito M; Kumano N; Motomiya M; Konno K; Yokosawa A
    Kekkaku; 1981 Jan; 56(1):11-6. PubMed ID: 7014973
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical and biological properties of subfractions of hot-water extract from delipidated BCG.
    Motomiya M; Sato H; Arai H; Nagai H; Ito M; Satoh K; Kumano N; Konno K
    Tohoku J Exp Med; 1981 Mar; 133(3):293-300. PubMed ID: 7314081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative immunogenicity of streptomycin-sensitive and -resistant strains of BCG.
    Collins FM; Montalbine V
    Infect Immun; 1973 Sep; 8(3):381-7. PubMed ID: 4199716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor effects of a novel immunomodulator, holding many bioactivities in common with endotoxins, derived from Mycobacterium bovis BCG].
    Ikeda-Fujita T; Kotani S; Tsujimoto M; Kato Y
    Nihon Saikingaku Zasshi; 1987 Nov; 42(6):851-5. PubMed ID: 3329246
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
    Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
    Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 12. Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.
    Hiu IJ
    Nat New Biol; 1972 Aug; 238(86):241-2. PubMed ID: 4562114
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
    Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical analyses and antitumor activity of hydrosoluble substances from Mycobacterium bovis, strain BCG.
    Sato H; Arai H; Nagai H; Ito M; Satoh K; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1983 May; 140(1):35-43. PubMed ID: 6191409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective activity of mycobacterial antigens. 3. Protective activity of killed mycobacterial bodies].
    Stavri D; Anagnoste V; Drăghici D
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):91-101. PubMed ID: 4936247
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
    Moroson H; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1683-8. PubMed ID: 4587143
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative immunogenicity of streptomycin-susceptible and -resistant strains of BCG. II. Effect of the route of inoculation on growth and immunogenicity.
    Collins FM; Montalbine V
    Am Rev Respir Dis; 1975 Jan; 111(1):43-51. PubMed ID: 1089372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.